Epidemiology of Melanoma in Spain: Estimation of Number of Patients With Stage III Disease Eligible for Adjuvant Therapies E. Nagore, D. Moreno-Ramírez, P. Ortiz-Romero, E. Martín-Sánchez, A. Martínez-Fernández, S. Puig

Immunotherapy and Targeted Therapy in Patients With Advanced Melanoma and the V600 BRAF Mutation: Which One First? D. Moreno-Ramírez, A. Fernández-Orland, L. Ferrándiz

Real-World Experience with Anifrolumab in Cutaneous Lupus Erythematosus: Data from a Spanish Tertiary Referral Center M. Viedma-Martinez, G. Gallo-Pineda, D. Jimenez-Gallo, M. Linares-Barrios